Multiple Sclerosis over the last 25 years: an introduction. 2018

G Edan
Department of neurology, CIC-P 02-03 Inserm, INCR, CHU de Rennes, 2, rue Henri-le-Guilloux, 35000 Rennes, France. Electronic address: gilles.edan@chu-rennes.fr.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Edan
October 1972, The Medical journal of Australia,
G Edan
January 1973, Repura. Leprosy,
G Edan
January 1986, Acta medicinae legalis et socialis,
G Edan
July 2012, Journal of anaesthesiology, clinical pharmacology,
G Edan
September 2006, Statistics in medicine,
G Edan
November 2020, Seminars in thrombosis and hemostasis,
G Edan
September 2000, The Journal of hand surgery,
G Edan
January 2016, International journal of cardiology,
Copied contents to your clipboard!